Cargando…
MicroRNA-134 as a potential plasma biomarker for the diagnosis of acute pulmonary embolism
BACKGROUND: Acute pulmonary embolism (APE) remains a diagnostic challenge due to a variable clinical presentation and the lack of a reliable screening tool. MicroRNAs (miRNAs) regulate gene expression in a wide range of pathophysiologic processes. Circulating miRNAs are emerging biomarkers in heart...
Autores principales: | Xiao, Junjie, Jing, Zhi-Cheng, Ellinor, Patrick T, Liang, Dandan, Zhang, Hong, Liu, Ying, Chen, Xiaoli, Pan, Lei, Lyon, Robert, Liu, Yi, Peng, Lu-Ying, Liang, Xingqun, Sun, Yunfu, Popescu, Laurentiu M, Condorelli, Gianluigi, Chen, Yi-Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189884/ https://www.ncbi.nlm.nih.gov/pubmed/21943159 http://dx.doi.org/10.1186/1479-5876-9-159 |
Ejemplares similares
-
miRNA-940 reduction contributes to human Tetralogy of Fallot development
por: Liang, Dandan, et al.
Publicado: (2014) -
Ruyiping formula inhibits metastasis via the microRNA-134-SLUG axis in breast cancer
por: Jiang, Ziwei, et al.
Publicado: (2021) -
MicroRNA-134 plasma levels before and after treatment with valproic acid for epilepsy patients
por: Wang, Xiaofeng, et al.
Publicado: (2017) -
Prolyl hydroxylase 2: a novel regulator of β(2)-adrenoceptor internalization
por: Yan, Biao, et al.
Publicado: (2011) -
The Predictive Value of microRNA-134 and microRNA-1233 for the Early Diagnosis of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Acute Pulmonary Embolism
por: Peng, Ling, et al.
Publicado: (2020)